The effects of elevated BMI and obesity alter cardiac hemodynamics and probably contribute to the development of LVH in this cohort through systemic inflammation, insulin resistance, and subsequent cardiac remodelling, termed obesity cardiomyopathy (22). This evidence concerns the gene INS and Obesity.